Related Experiment Video

Updated: Jul 19, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

[Clinical study of 90 cases of Mycoplasma pneumoniae pneumonia]

Yousuke Miyahar1, Noboru Takayanagi, Motoko Kubota

  • 1Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center.

Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society
|October 14, 2006
PubMed

Insights

Severe Mycoplasma pneumoniae pneumonia is common. Without rapid diagnostic tests, Mycoplasma pneumoniae (M. pneumoniae) pneumonia deaths may be underestimated, impacting accurate mortality rates.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Context:

  • Mycoplasma pneumoniae (M. pneumoniae) is a common cause of community-acquired pneumonia.
  • Accurate diagnosis of M. pneumoniae pneumonia can be challenging, especially in severe cases.
  • Current diagnostic methods may not always identify the pathogen promptly.

Purpose:

  • To investigate the clinical characteristics and outcomes of patients with Mycoplasma pneumoniae pneumonia.
  • To assess the severity and mortality associated with M. pneumoniae pneumonia.
  • To highlight the importance of diagnostic methods for M. pneumoniae detection.

Summary:

  • This study analyzed 90 patients with M. pneumoniae pneumonia, noting demographic data, comorbidities, and diagnostic methods (culture, antibody titers).
  • Severity was assessed using Japanese and American Thoracic Society criteria, with some patients requiring mechanical ventilation or experiencing fatal outcomes.
  • M. pneumoniae was identified as the causative agent in fatal cases, sometimes alongside polymicrobial infections, underscoring the need for effective detection.

Impact:

  • Severe M. pneumoniae pneumonia is not rare and can lead to significant morbidity and mortality.
  • The study suggests that current mortality rates for M. pneumoniae pneumonia may be underestimated due to diagnostic limitations.
  • Implementing rapid diagnostic kits or improved culture methods is crucial for timely pathogen identification and management.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: